drugset / Trial / NCT01435980

Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes

NCT01435980

Phase 4 Unknown 60 enrolled Wu Qinan
RandomizedParallel-groupOpen-labelTreatment

Summary

Objectives: To investigate the treatment effect between Gastric Bypass and Exenatide in Type 2 Diabetes in our hospital, in order to investigate the possible mechanism of Gastric Bypass and Exenatide.

Timeline

Start
2008-02
Primary completion
2016-01
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Exenatide Peptide